Rocket Lab Schedules First Dedicated Launch for Japan Aerospace Exploration Agency (JAXA) GlobeNewswire November 24, 2025 LONG BEACH, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced the launch window for the first of two dedicated […]

WillScot Announces Investor Conference Schedule for December 2025 GlobeNewswire November 24, 2025 SCOTTSDALE, Ariz., Nov. 24, 2025 (GLOBE NEWSWIRE) — WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced that it will participate in the following investor conferences: Bank of America Leveraged Finance ConferenceDate: December 2,

Eos Energy Successfully Closes $600 Million Convertible Senior Notes Offering and Registered Direct Offering of Common Stock, Enhancing Financial Liquidity and Fueling U.S. Manufacturing Expansion Transactions strengthen the Company's balance sheet by lowering debt interest rate while improving liquidity to accelerate capacity expansion for American-made long duration energy storage GlobeNewswire November 24, 2025 EDISON, N.J.,

Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th GlobeNewswire November 24, 2025 DEER PARK, Ill., Nov. 24, 2025 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that members of the

Tarsus to Participate in Upcoming Investor Conference GlobeNewswire November 24, 2025 IRVINE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in a fireside chat at the BTIG 5th Annual Ophthalmology Day on Monday, December 1st, at 10:45 a.m. PT / 1:45 p.m. ET. A live

XMax Inc. Announces US$5 Million Convertible Note Financing GlobeNewswire November 24, 2025 LOS ANGELES, Nov. 24, 2025 (GLOBE NEWSWIRE) — XMax Inc., a Nevada corporation (“XMax” or the “Company”) (NASDAQ: XWIN) today announced that on November 18, 2025, it entered into a Convertible Promissory Note Purchase Agreement with Billiongold Holding Limited, pursuant to which the

Paul Mueller Company Announces Expiration of Share Repurchase Program GlobeNewswire November 24, 2025 SPRINGFIELD, Mo., Nov. 24, 2025 (GLOBE NEWSWIRE) — Paul Mueller Company (OTC: MUEL) today announced that the tender offer, announced on October 24, 2025, expired on November 21, 2025, with 31,000 shares being tendered for a total of $15,035,000. On November 25,

Onco360(R) Has Been Selected as The National Specialty Pharmacy Partner for HYRNUO(R) (sevabertinib) GlobeNewswire November 24, 2025 LOUISVILLE, Ky., Nov. 24, 2025 (GLOBE NEWSWIRE) — Onco360(R), the nation's leading independent Specialty Pharmacy, has been selected as the national pharmacy partner by Bayer Pharmaceuticals for HYRNUO(R) (sevabertinib). The Food and Drug Administration approved HYRNUO for the

Ultragenyx to Participate in Investor Conferences in December GlobeNewswire November 24, 2025 NOVATO, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced participation in two upcoming investor conferences. Citi's 2025 Global

(NYSE:SLQT), BOSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) — Berman Tabacco, a national law firm representing investors, announces its investigation into potential stockholder claims involving SelectQuote, Inc. (“SelectQuote”) (NYSE:SLQT) allegedly receiving illegal payments from health insurance providers. About the Investigation Allegations that SelectQuote received illegal payments and other claims were unsealed in May 2025 after the